IVZ vs BEN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IVZ · Invesco$26.51 ▼ 4.54%
BEN · Franklin Templeton$32.04 ▼ 3.70%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IVZ +14.7%
- BEN +52.5%
Head to head
| Metric | IVZ | BEN |
|---|---|---|
| Price | $26.51 | $32.04 |
| Change today | ▼ 4.54% | ▼ 3.70% |
| Market cap | $11.65B | $16.38B |
| Return, 3 months | -17.7% | -6.5% |
| Return, year to date | +4.0% | +38.8% |
| Return, 1 year | +17.7% | +55.0% |
| P/E (TTM) | – | 16.3 |
| P/B | 1.2 | 1.4 |
| P/E percentile vs own 5y | 7th | 54th |
| Dividend yield | 3.21% | 4.12% |
| Revenue growth (YoY, latest qtr) | +14.2% | +3.9% |
| Net profit growth (YoY) | -0.2% | +194.0% |
| Gross margin | 37.1% | 81.4% |
| Operating margin | -4.5% | 14.5% |
| Net margin | -4.4% | 10.8% |
| Return on equity | -3.0% | 8.5% |
| Analyst target vs. price | +36.8% | +16.6% |
| Analyst buy share | 50% | 36% |
| RSI (14) | 38 | 42 |
| 30-day volatility | 45.7% | 40.2% |
| Max drawdown, 1 year | -22.0% | -19.2% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BEN is the largest of the group by market value.
- BEN has returned the most over the past year.
- BEN pays the highest dividend yield.
- IVZ is growing revenue fastest.
- BEN keeps the most profit per dollar of sales.
- BEN has been the calmest stock over the last 30 days.